Abstract
A 30-year-old man presented with altered sensorium following Russell’s viper bite, which was found to be secondary to intracranial hemorrhage secondary to venom-induced consumptive coagulopathy. He was managed conservatively with blood component transfusion and antivenom injection, and successfully discharged.
Keywords: poisoning, adult intensive care, neuro ITU
Background
Snake envenomation is a potentially lethal health problem widely seen in tropical countries, and is recognised as a neglected tropical disease by WHO, accounting for about 125 000 deaths per year.1 Most snakebites are inflicted by non-poisonous snakes and only 15% of snakes are considered poisonous. The family Viperidae is the largest family of poisonous snakes followed by Elapidae and the subfamily Crotalidae. Cerebrovascular complications following snakebite is rare, but both haemorrhagic and thrombotic complications have been reported in the literature.2 3 Viperine bites are the most common bites found in India and majority are due to Russell’s viper, and manifest as coagulopathy or systemic haemorrhage.4
Case presentation
A 30-year-old chronic alcoholic non-diabetic non-hypertensive man presented with altered sensorium following a history of Russell’s viper (Daboia russelii) bite. There was no history of abnormal haemorrhage, oliguria, head trauma, vomiting, seizures or headache.
On examination, he had a Glasgow Coma Scale of 9 (E2V3M4), and bilateral upgoing plantar reflexes. There was no other abnormality on systemic examination, or signs of raised intracranial pressure.
Investigations
There was no detectable abnormality in haemogram, except for mild thrombocytopenia (platelet count 110×109/L). Renal and liver function tests were normal. He had mild hyponatremia (Na 131 mEq/L), with normal blood glucose. Twenty minutes whole blood clotting time was prolonged, he had elevated prothrombin time (INR 1.56), activated thromboplastin time, fibrinogen degradation product (FDP) (12.69 µg/mL (normal <10)) and d-dimer (2694 ng/mL (normal <500)).
Non-contrast computed tomography (NCCT) of head revealed multiple intraparenchymal haemorrhages in bilateral frontal, parietal and temporal regions, with no evidence of bony injury (figure 1).
Figure 1.

Non-contrast CT of head (axial section) showing multiple intraparenchymal haemorrhages in bilateral frontal, parietal and temporal regions, with no evidence of bony injury.
Differential diagnosis
The possibility of viper-bite-induced coagulopathy resulting in intracranial haemorrhage was kept as the primary diagnosis. Alcohol-induced liver dysfunction was ruled out in view of otherwise normal liver function test and no evidence of portal hypertension.
Treatment
In view of deranged coagulation parameters with intracranial haemorrhage, he was started on polyvalent antivenom therapy immediately on arrival, and was managed conservatively with fresh frozen plasma and platelet concentrate transfusion. Local wound asepsis was maintained, and he was discharged well on day 5 of hospital stay, and he was able to ambulate with support.
Outcome and follow-up
Repeat NCCT brain at 30-day follow-up shows regression of previous haemorrhages and normalisation of coagulation parameters including FDP (1.4 µg/mL) and d-dimer (0.74 ng/mL) values. There was no residual neurological deficit.
Discussion
The pathophysiology of snake envenomation-related coagulopathy is not fully understood. Various components in venom have separate roles in the spread of the toxin and its resultant systemic effect.5 Venom-induced consumptive coagulopathy (VICC) is the most common coagulation abnormality resulting from viperine venom, which has different concentrations of enzymes including proteases, phospholipase A2, hyaluronidase and arginine ester hydrolase.6 The hyaluronidase facilitates venom spread by disrupting mucopolysaccharides in the tissue, while phospholipase A2 causes haemolysis secondary to the lysis of red cell membranes, as well as causing myonecrosis.
Thrombogenic enzymes promote the formation of weak fibrin clots, resulting in the activation of plasmin, which leads to consumption of coagulation factors and haemorrhage.7 Prothrombin activators such as ecarin and carina activase cause reductions in factors V, VII and fibrinogen levels.6
Al-Sadawi et al reviewed 83 cases with acute cerebrovascular accident following snake envenomation, out of which one-fifth had intracranial haemorrhage, out of which Russel’s viperine bite was associated with higher mortality.8 Ehelepola et al reported a 52-year-old man who expired due to intracranial haemorrhage attributed to VICC.9
Our patient had deranged coagulation parameters and increased levels of FDP, suggesting VICC as the cause for intracerebral haemorrhage. Changes in laboratory parameters do not always correlate with actual risk of haemorrhage. Similarly, after initial correction, clinical relapse with the return of deranged coagulation parameters are well recognised, which is supposedly the result of delayed leaching of venom from deeper areas in the bite site or the disruption of the antigen–antibody complexes, with recirculation of unbound venom constituents.9
Learning points.
Spontaneous intracranial bleed is an uncommon manifestation of hematotoxic snake bite and can often be misleading for the clinician.
Venom-induced consumptive coagulopathy has been reported in viperine bites, but has rarely been associated with intracranial haemorrhage.
Early identification of aetiology and correction of haemorrhaging diathesis is the mainstay of treatment, along with antivenom administration.
Footnotes
Contributors: MC: patient management, literature review and preparation of the initial draft of the manuscript. DB: critical review of the manuscript for important intellectual content and final approval of the version to be published.
Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests: None declared.
Patient consent for publication: Obtained.
Provenance and peer review: Not commissioned; externally peer reviewed.
References
- 1.Kasturiratne A, Wickremasinghe AR, de Silva N, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med 2008;5:e218. 10.1371/journal.pmed.0050218 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gouda S, Pandit V, Seshadri S, et al. Posterior circulation ischemic stroke following Russell's viper envenomation. Ann Indian Acad Neurol 2011;14:301–3. 10.4103/0972-2327.91957 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ittyachen AM, Jose MB. Thalamic infarction following a Russell’s viper bite. Southeast Asian J Trop Med Pub Health 2012;43:1201–4. [PubMed] [Google Scholar]
- 4.Kumar KS, Narayanan S, Udayabhaskaran V, et al. Clinical and epidemiologic profile and predictors of outcome of poisonous snake bites - an analysis of 1,500 cases from a tertiary care center in Malabar, North Kerala, India. Int J Gen Med 2018;11:209–16. 10.2147/IJGM.S136153 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med 2002;347:347–56. 10.1056/NEJMra013477 [DOI] [PubMed] [Google Scholar]
- 6.Maduwage K, Isbister GK. Current treatment for venom-induced consumption coagulopathy resulting from snakebite. PLoS Negl Trop Dis 2014;8:e3220. 10.1371/journal.pntd.0003220 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Cortelazzo A, Guerranti R, Bini L, et al. Effects of snake venom proteases on human fibrinogen chains. Blood Transfus 2010;8(Suppl 3):120–5. 10.2450/2010.019S [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Al-Sadawi M, Mohamadpour M, Zhyvotovska A, et al. Cerebrovascular accident and snake envenomation: a scoping study. Int J Clin Res Trials 2019;4:133. 10.15344/2456-8007/2019/13331528777 [DOI] [Google Scholar]
- 9.Ehelepola NDB, Samaranayake SMAN, Basnayake BMLS, et al. Multisystem failure and death due to extensive hemorrhaging and brain herniation subsequent to a bite by an unidentified snake. Trop Med Health 2016;44:29. 10.1186/s41182-016-0029-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
